<DOC>
	<DOCNO>NCT02191215</DOCNO>
	<brief_summary>The aim Post Marketing Study ( PMS ) evaluate efficacy safety profile nevirapine management HIV/AIDS open environment .</brief_summary>
	<brief_title>Clinical Therapeutic Evaluation Infection HIV/AIDS</brief_title>
	<detailed_description />
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<criteria>diagnosis HIV/AIDS , age limit patient could na√Øve treatment pretreated antiretroviral agent Patients know hypersensitivity nevirapine component product</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>